Next Article in Journal
IGF-1 Antibody Prolongs the Effective Duration Time of Botulinum Toxin in Decreasing Muscle Strength
Next Article in Special Issue
Neuroprotective Effect of Melatonin: A Novel Therapy against Perinatal Hypoxia-Ischemia
Previous Article in Journal
Ribonucleoprotein Complexes That Control Circadian Clocks
Previous Article in Special Issue
New Radioligands for Describing the Molecular Pharmacology of MT1 and MT2 Melatonin Receptors
Review

Role of Melatonin in Schizophrenia

1
Department of Internal Medicine, Dermatology and Psychiatry, School of Medicine, University of La Laguna, 38071 La Laguna, Spain
2
Psychiatric Consultancy SC, 38001 Santa Cruz de Tenerife, Spain
3
Department of Physiology, School of Medicine, University of La Laguna, 38071 La Laguna, Spain
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2013, 14(5), 9037-9050; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms14059037
Received: 19 February 2013 / Revised: 9 April 2013 / Accepted: 10 April 2013 / Published: 25 April 2013
(This article belongs to the Special Issue Advances in the Research of Melatonin)
Schizophrenia is a chronic mental disease that disturbs several cognitive functions, such as memory, thought, perception and volition. Schizophrenia’s biological etiology is multifactorial and is still under investigation. Melatonin has been involved in schizophrenia since the first decades of the twentieth century. Research into melatonin regarding schizophrenia has followed two different approaches. The first approach is related to the use of melatonin as a biological marker. The second approach deals with the clinical applications of melatonin as a drug treatment. In this paper, both aspects of melatonin application are reviewed. Its clinical use in schizophrenia is emphasized. View Full-Text
Keywords: melatonin; schizophrenia; biological marker; therapeutic agent melatonin; schizophrenia; biological marker; therapeutic agent
MDPI and ACS Style

Morera-Fumero, A.L.; Abreu-Gonzalez, P. Role of Melatonin in Schizophrenia. Int. J. Mol. Sci. 2013, 14, 9037-9050. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms14059037

AMA Style

Morera-Fumero AL, Abreu-Gonzalez P. Role of Melatonin in Schizophrenia. International Journal of Molecular Sciences. 2013; 14(5):9037-9050. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms14059037

Chicago/Turabian Style

Morera-Fumero, Armando L., and Pedro Abreu-Gonzalez. 2013. "Role of Melatonin in Schizophrenia" International Journal of Molecular Sciences 14, no. 5: 9037-9050. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms14059037

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop